Latest Questcor Pharmaceuticals (QCOR) Headlines
Post# of 6
Posted On: 03/13/2014 1:03:52 PM
Latest Questcor Pharmaceuticals (QCOR) Headlines
Pipeline Update at BioLineRx - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 4:50PM CDT
BioLineRx announced the successful completion of the single administration, dose-escalation stage of the ongoing phase I/II study on BL-7010
Is A Short Squeeze Ahead for Questcor Pharmaceuticals (QCOR)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 9:25AM CDT
Is A Short Squeeze Ahead for Questcor Pharmaceuticals (QCOR)?
Zogenix (ZGNX) Jumps: Stock Moves 11.8% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 8:25AM CDT
Zogenix was a big mover last session, with shares rising nearly 12%.
What Falling Estimates & Price Mean for Tetraphase Pharmaceuticals (TTPH) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 8:15AM CDT
One such stock that you may want to consider dropping is Tetraphase Pharmaceuticals which witnessed negative earnings estimate revisions in current quarter and current year.
Can Ohr Pharmaceutical (OHRP) Continue to Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 7:52AM CDT
Ohr Pharmaceutical has seen its Zacks Rank surge over the past four weeks, moving from Sell territory to its current position as a Buy
Look for Shares of Questcor Pharmaceuticals to Potentially Rebound after Yesterday's 2.30% Sell Off
Comtex SmarTrend(R) - Mon Mar 10, 5:45PM CDT
Questcor Pharmaceuticals (NASDAQ:QCOR) traded in a range yesterday that spanned from a low of $62.82 to a high of $65.86. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $63.30 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Questcor Pharmaceuticals Earnings In Retrospect: Down 16.1% in the Last 13 Days (QCOR)
Comtex SmarTrend(R) - Mon Mar 10, 7:50AM CDT
A week ago on February 25th, 2014 Questcor Pharmaceuticals (NASDAQ:QCOR) reported earnings and analysts, on average, expected earnings of $1.66 on sales of $244.1 million. Questcor Pharmaceuticals actually reported earnings of $1.67 per share on sales of $242.9 million, beating EPS estimates by $0.01 and missing revenue estimates by $1.2 million. Since the company's report, shares of Questcor Pharmaceuticals have fallen from $78.65 to $66.00, representing a loss of 16.1% in the past 13 days.
Rigel (RIGL) Worth Watching: Stock Rises 10.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 8:46AM CST
Rigel was a big mover last session, as the company saw its shares rise over 10% on the day.
ArQule's Loss Narrows in Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 12:37PM CST
ArQule reported a loss of 10 cents per share in the fourth quarter of 2013, narrower than the Zacks Consensus Estimate of a loss of 13 cents per share.
Avanir (AVNR) Catches Eye: Stock Soars 16.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 8:25AM CST
Avanir was a big mover last session, as the company saw its shares rise over 16% on the day.
Look for Shares of Questcor Pharmaceuticals to Potentially Pullback after Yesterday's 3.54% Rise
Comtex SmarTrend(R) - Wed Mar 05, 4:31PM CST
Questcor Pharmaceuticals (NASDAQ:QCOR) traded in a range yesterday that spanned from a low of $65.03 to a high of $67.55. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $67.27 on volume of 3.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
'Mad Money' Lightning Round: Stay Away From Questcor Pharmaceuticals
at The Street - Tue Mar 04, 5:00AM CST
Cramer would rather buy Talisman Energy than sell it and he feels good about Drew Industries.
Jim Cramer's 'Mad Money' Recap: Stop Panicking
at The Street - Mon Mar 03, 7:08PM CST
Ukraine is just another in a long list of foreign crises that have the markets operating on emotion instead of logic, Cramer says.
Why Questcor Pharmaceuticals, Inc. Shares Briefly Popped
Sean Williams, The Motley Fool - Motley Fool - Mon Mar 03, 1:17PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Questcor Pharmaceuticals , a...
Stocks Down Hard But Up Slightly From Session Lows
at Investor's Business Daily - Mon Mar 03, 12:33PM CST
Stocks were off intraday lows but still down hard in afternoon trading as Russia's military action in Ukraine's Crimea region continued to stoke geopolitical fears. The Nasdaq was down 1.2%, the Dow 1.1% and the S&P 500 0.9%. Volume was mixed, with...
Today's Dead Cat Bounce Stock Is Questcor Pharmaceuticals (QCOR)
at The Street - Mon Mar 03, 8:58AM CST
Trade-Ideas LLC identified Questcor Pharmaceuticals (QCOR) as a "dead cat bounce" (down big yesterday but up big today) candidate
3 Horrendous Health-Care Stocks This Week
Keith Speights, The Motley Fool - Motley Fool - Sat Mar 01, 6:00AM CST
Another month in 2014 has drawn to a close -- as has another week of horrendous performances by several health-care stocks. February is the shortest month of the year, but its final week proved to be quite a long one for some investors. One of this...
Questcor Pharmaceuticals Falls 9.96% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Feb 28, 4:20PM CST
Questcor Pharmaceuticals (NASDAQ:QCOR) traded in a range yesterday that spanned from a low of $60.05 to a high of $64.79. Yesterday, the shares fell 10.0%, which took the trading range below the 3-day low of $64.82 on volume of 8.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Stocks Hold Near Fresh Highs; 58.com Surges
at Investor's Business Daily - Fri Feb 28, 11:04AM CST
Stocks were holding near their session highs near Friday's midpoint. Overall, equities rallied in spite of a round of mixed economic data, including a downward revision to economic growth. The S&P 500 and the Nasdaq were up 0.5% and 0.2%,...
Questcor Pharmaceuticals Beats Zacks Consensus; Cobalt International Energy Rises Despite Disappointing Q4
ACCESSWIRE - Thu Feb 27, 11:35PM CST
Transocean Ltd. (NYSE: RIG) - For an in-depth report on Transocean Ltd. follow: www.BullTrends.com/stockquote/RIG
Pipeline Update at BioLineRx - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 4:50PM CDT
BioLineRx announced the successful completion of the single administration, dose-escalation stage of the ongoing phase I/II study on BL-7010
Is A Short Squeeze Ahead for Questcor Pharmaceuticals (QCOR)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 9:25AM CDT
Is A Short Squeeze Ahead for Questcor Pharmaceuticals (QCOR)?
Zogenix (ZGNX) Jumps: Stock Moves 11.8% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 8:25AM CDT
Zogenix was a big mover last session, with shares rising nearly 12%.
What Falling Estimates & Price Mean for Tetraphase Pharmaceuticals (TTPH) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 8:15AM CDT
One such stock that you may want to consider dropping is Tetraphase Pharmaceuticals which witnessed negative earnings estimate revisions in current quarter and current year.
Can Ohr Pharmaceutical (OHRP) Continue to Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 7:52AM CDT
Ohr Pharmaceutical has seen its Zacks Rank surge over the past four weeks, moving from Sell territory to its current position as a Buy
Look for Shares of Questcor Pharmaceuticals to Potentially Rebound after Yesterday's 2.30% Sell Off
Comtex SmarTrend(R) - Mon Mar 10, 5:45PM CDT
Questcor Pharmaceuticals (NASDAQ:QCOR) traded in a range yesterday that spanned from a low of $62.82 to a high of $65.86. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $63.30 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Questcor Pharmaceuticals Earnings In Retrospect: Down 16.1% in the Last 13 Days (QCOR)
Comtex SmarTrend(R) - Mon Mar 10, 7:50AM CDT
A week ago on February 25th, 2014 Questcor Pharmaceuticals (NASDAQ:QCOR) reported earnings and analysts, on average, expected earnings of $1.66 on sales of $244.1 million. Questcor Pharmaceuticals actually reported earnings of $1.67 per share on sales of $242.9 million, beating EPS estimates by $0.01 and missing revenue estimates by $1.2 million. Since the company's report, shares of Questcor Pharmaceuticals have fallen from $78.65 to $66.00, representing a loss of 16.1% in the past 13 days.
Rigel (RIGL) Worth Watching: Stock Rises 10.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 8:46AM CST
Rigel was a big mover last session, as the company saw its shares rise over 10% on the day.
ArQule's Loss Narrows in Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 12:37PM CST
ArQule reported a loss of 10 cents per share in the fourth quarter of 2013, narrower than the Zacks Consensus Estimate of a loss of 13 cents per share.
Avanir (AVNR) Catches Eye: Stock Soars 16.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 8:25AM CST
Avanir was a big mover last session, as the company saw its shares rise over 16% on the day.
Look for Shares of Questcor Pharmaceuticals to Potentially Pullback after Yesterday's 3.54% Rise
Comtex SmarTrend(R) - Wed Mar 05, 4:31PM CST
Questcor Pharmaceuticals (NASDAQ:QCOR) traded in a range yesterday that spanned from a low of $65.03 to a high of $67.55. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $67.27 on volume of 3.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
'Mad Money' Lightning Round: Stay Away From Questcor Pharmaceuticals
at The Street - Tue Mar 04, 5:00AM CST
Cramer would rather buy Talisman Energy than sell it and he feels good about Drew Industries.
Jim Cramer's 'Mad Money' Recap: Stop Panicking
at The Street - Mon Mar 03, 7:08PM CST
Ukraine is just another in a long list of foreign crises that have the markets operating on emotion instead of logic, Cramer says.
Why Questcor Pharmaceuticals, Inc. Shares Briefly Popped
Sean Williams, The Motley Fool - Motley Fool - Mon Mar 03, 1:17PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Questcor Pharmaceuticals , a...
Stocks Down Hard But Up Slightly From Session Lows
at Investor's Business Daily - Mon Mar 03, 12:33PM CST
Stocks were off intraday lows but still down hard in afternoon trading as Russia's military action in Ukraine's Crimea region continued to stoke geopolitical fears. The Nasdaq was down 1.2%, the Dow 1.1% and the S&P 500 0.9%. Volume was mixed, with...
Today's Dead Cat Bounce Stock Is Questcor Pharmaceuticals (QCOR)
at The Street - Mon Mar 03, 8:58AM CST
Trade-Ideas LLC identified Questcor Pharmaceuticals (QCOR) as a "dead cat bounce" (down big yesterday but up big today) candidate
3 Horrendous Health-Care Stocks This Week
Keith Speights, The Motley Fool - Motley Fool - Sat Mar 01, 6:00AM CST
Another month in 2014 has drawn to a close -- as has another week of horrendous performances by several health-care stocks. February is the shortest month of the year, but its final week proved to be quite a long one for some investors. One of this...
Questcor Pharmaceuticals Falls 9.96% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Feb 28, 4:20PM CST
Questcor Pharmaceuticals (NASDAQ:QCOR) traded in a range yesterday that spanned from a low of $60.05 to a high of $64.79. Yesterday, the shares fell 10.0%, which took the trading range below the 3-day low of $64.82 on volume of 8.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Stocks Hold Near Fresh Highs; 58.com Surges
at Investor's Business Daily - Fri Feb 28, 11:04AM CST
Stocks were holding near their session highs near Friday's midpoint. Overall, equities rallied in spite of a round of mixed economic data, including a downward revision to economic growth. The S&P 500 and the Nasdaq were up 0.5% and 0.2%,...
Questcor Pharmaceuticals Beats Zacks Consensus; Cobalt International Energy Rises Despite Disappointing Q4
ACCESSWIRE - Thu Feb 27, 11:35PM CST
Transocean Ltd. (NYSE: RIG) - For an in-depth report on Transocean Ltd. follow: www.BullTrends.com/stockquote/RIG
(0)
(0)Questcor Pharmaceuticals (QCOR) Stock Research Links
Scroll down for more posts ▼